SCHEMBL7666528

SCHEMBL7666528

Cc1sc2cccc(Oc3cccnc3)c2c1Cl

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ CYP19A1 P11511 3/20 0.39
▸ P2RX7 Q99572 1/20 0.36
▸ GRM5 P41594 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ PTGS1 P23219 1/20 0.34
▸ PTGS2 P35354 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ PRSS12 P56730 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11477740 0.69 TDP1 (0.53) LMNATDP1ALDH1A1SMN1; SMN2CYP19A1
SCHEMBL9922005 0.69 LMNA (0.53) LMNATDP1ALDH1A1SMN1; SMN2CYP19A1
SCHEMBL24701310 0.69 LMNA (0.46) LMNATDP1ALDH1A1SMN1; SMN2CYP19A1
SCHEMBL7879489 0.67 TDP1 (0.44) LMNATDP1ALDH1A1SMN1; SMN2CYP19A1
SCHEMBL14154413 0.66 MAPK1 (0.37) ALDH1A1NPC1MAPK1RAB9AMAPT
SCHEMBL18869413 0.66 MAPK1 (0.53) LMNATDP1ALDH1A1MAPK1MAPT
SCHEMBL7671126 0.66 ALDH1A1 (0.49) LMNATDP1ALDH1A1SMN1; SMN2CYP19A1
SCHEMBL11573009 0.66 ALDH1A1 (0.59) LMNATDP1ALDH1A1SMN1; SMN2CYP19A1
SCHEMBL14008970 0.65 LMNA (0.49) LMNATDP1ALDH1A1SMN1; SMN2CYP19A1
SCHEMBL4133572 0.65 TGFBR1 (0.53) LMNATDP1ALDH1A1SMN1; SMN2CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458813-B1 2-CYCLOHEXYLOXY-5-(2-CHLOROPHENYLCARBONYLAMINO)PYRIDINE, FOR EXAMPLE; TREATING INFLAMMATION, PAIN, DIABETES, CANCER AMGEN INC. 2002-10-01 — — US disclosed
US-6333341-B1 TUMOR NECROSIS FACTOR, ANTIINFLAMMATORY AGENTS AND ANALGESICS AMGEN INC. 2001-12-25 — — US disclosed
US-6184237-B1 Substituted pyridine compounds and methods of use AMGEN INC. 2001-02-06 — — US disclosed
Send feedback